← Leaderboards
Matthew Sidney Parsons
Emory University
$639,171
Attributed
$639,171
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $213.1K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$639,171 · 1
By mechanism
K01$639,171 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- John S. Lollar$19,901,192
- Rafi Ahmed$104,632,759
- Guido Silvestri$61,186,493
- Jeffrey Scott Hale$5,571,013
- Kathryn B Anderson$2,406,027
Others in their field
Other Emerging Leaders on “Glycoproteins”
- Priyamvada Acharya · Duke University$23,791,403
- Neil King · University Of Washington$11,515,635
- Eva Morava-Kozicz · Mayo Clinic Rochester$7,408,672
- Aaron Gregory Schmidt · Boston Children'S Hospital$7,228,583
- Alon Herschhorn · University Of Minnesota$6,792,305
- Jan Johansson · Artery Therapeutics, Inc.$5,837,069
Research focus
GlycoproteinsFc ReceptorAids PreventionDrug ToxicityExposure ToAdherenceAntiretroviral TherapyAntibodiesAntibody-Dependent Cell CytotoxicityBindingBlocking AntibodiesAnimalsCareer DevelopmentCell ModelCellsCharacteristicsClinical TrialsContractsCostCytoprotectionDesignDevelopment PlansDoseHigh Risk
Grant awards (3)
Assessing if distinct susceptibility to neutralization of cell-free and cell-to-cell spread impacts antibody conferred protection from SHIV infection$213,057
K01 · FY2023 · OD · contact PI
Assessing if distinct susceptibility to neutralization of cell-free and cell-to-cell spread impacts antibody conferred protection from SHIV infection$213,057
K01 · FY2022 · OD · contact PI
Assessing if distinct susceptibility to neutralization of cell-free and cell-to-cell spread impacts antibody conferred protection from SHIV infection$213,057
K01 · FY2021 · OD · contact PI